Biosimilar Year In Review: Regulatory Achievements And Future Aspirations

Biosimilar Year In Review: Regulatory Achievements And Future Aspirations

This year, regulators questioned the US interchangeability designation and the need for comparative efficacy trials, while finding ways to promote...
13 hours ago
from: insights.citeline.com

Continue reading...
Biosimilar, Health care
More about this
- Biosimilars Market Size to Worth USD 114.02 Billion By 2031
According to Coherent Market Insights, the global biosimilars market size is calculated at USD 36.01 Billion in 2024 and is projected to...
from: BioSpace
- What’s the Difference: Biologics vs Biosimilars in Cancer Care
An experienced oncology nurse in a community practice clinic prepares for the arrival of a 65-year-old patient with metastatic breast cancer...
from: Oncology Nursing News
- Exploring Biosimilar Adoption and Policy Impacts in Oncology
In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted...
from: HMP Global Learning Network
- Specialty Pharmacist Working to Improve Biosimilar Adoption
Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, works in the supply chain and finance field as a pharmaceutical...
from: Drug Topics
- Fast Facts - Everything there is to know about biosimilars
Biologic medicines have transformed the treatment of numerous serious disorders. Biosimilars, offering comparable safety and efficacy at a...
from: News-Medical
- New Report on Biosimilar Market Potential and Challenges
Advancing Access and Affordability: How Biosimilars Benefit Patients and Providers. WASHINGTON, Dec. 17, 2024 /PRNewswire/ -- Biosimilars could lower the...
from: WDTN.com
- 4 key barriers holding biosimilars back (and how to remove them)
Spending on prescription drugs rose 9.9% in 2023 alone, while pharmacy benefits remained the fastest growing component of health care in...
from: BenefitsPro
- Biosimilar Market expected to reach USD 343,520.90 million by 2030
This Biosimilar market report has been prepared by considering several fragments of the present Biosimilar market Biosimilar market and...
from: openPR.com
- Biosimilars Market Sector Dynamics: Industry Size, Share,
Global biosimilars market is estimated to be valued at USD 36.01 Bn in 2024 and is expected to reach USD 114.02 Bn by 2031, exhibiting a...
from: openPR.com